𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in chondrosarcoma. A comparative study of cellular DNA content and clinicopathologic features

✍ Scribed by Andris Kreicbergs; Lennart Boquist; Bengt Borssén; Sven-Erik Larsson


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
669 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prognostic factors in uterine carcinosar
✍ Yoko Iwasa; Hironori Haga; Ikuo Konishi; Yoichiro Kobashi; Kayoko Higuchi; Eiji 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

## Background: Carcinosarcoma (malignant mixed mullerian tumor) of the female genital tract is a highly malignant neoplasm. the tumor stage and histologic grade of the carcinomatous component are among the important prognostic indicators cited in the literature for this tumor. ## Methods: Twenty-

Prognostic factors in cystosarcoma phyll
✍ Gabriella Cohn-Cedermark; Lars E. Rutqvist; Ingvar Rosendahl; Claes Silfverswärd 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

The authors studied prognostic factors in 77 patients with primary cystosarcoma phyllodes (CSP) of the breast. Median patient age was 50 years of age, and the median follow-up time was 8 years. Sixteen patients (21'/0) had distant metastases and subsequently died of CSP. Clinical variables such as a

Liposarcoma: A population-based epidemio
✍ Pelle Gustafson; Anders Rydholm; Helena Willén; Måns Åkerman; Bo Baldetorp; Mårt 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 840 KB

## Abstract Different conceptions exist regarding the epidemiology and prognosis of liposarcoma, and several classification systems are in use. We analyzed a population‐based, 25‐year series of 43 patients with liposarcoma of the extremity or trunk wall. Follow‐up was complete. The annual incidence

Prognostic value and clinicopathologic c
✍ Alan G. Casson; Sheryl McCuaig; Ian Craig; Adel Ayed; Richard Inculet; Nancy Ker 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

The aim of this prospective study was to determine whether use of a combination of biomarkers, p53 and nuclear DNA content, led to improved prognosis and clinicopathologic correlation in human non-small cell lung cancer. Nineteen patients undergoing curative resection of p imary non-small cell lung